3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
66
EFX Quote, Financials, Valuation and Earnings
Last price:
$243.33
Seasonality move
:
6.91%
Day range:
$238.44 - $244.80
52-week range:
$213.02 - $309.63
Dividend yield:
0.64%
P/E ratio:
50.43x
P/S ratio:
5.36x
P/B ratio:
6.30x
Volume:
736.9K
Avg. volume:
1.1M
1-year change:
-8.96%
Market cap:
$30.2B
Revenue:
$5.7B
EPS (TTM):
$4.83
Analysts' Opinion
-
Consensus RatingEquifax has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $289.64, Equifax has an estimated upside of 18.92% from its current price of $243.56.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $264.00 representing 100% downside risk from its current price of $243.56.
Fair Value
-
According to the consensus of 15 analysts, Equifax has 18.92% upside to fair value with a price target of $289.64 per share.
EFX vs. S&P 500
-
Over the past 5 trading days, Equifax has overperformed the S&P 500 by 1.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Equifax does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Equifax has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Equifax reported revenues of $1.4B.
Earnings Growth
-
Equifax has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Equifax reported earnings per share of $1.39.
Enterprise value:
35.2B
EV / Invested capital:
--
Price / LTM sales:
5.36x
EV / EBIT:
33.83x
EV / Revenue:
6.19x
PEG ratio (5yr expected):
5.16x
EV / Free cash flow:
43.26x
Price / Operating cash flow:
37.43x
Enterprise value / EBITDA:
20.45x
Gross Profit (TTM):
$3.2B
Return On Assets:
4.97%
Net Income Margin (TTM):
10.63%
Return On Equity:
12.48%
Return On Invested Capital:
5.86%
Operating Margin:
20.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.1B | $5.3B | $5.7B | $1.3B | $1.4B | |
| Gross Profit | $2.9B | $2.9B | $3.2B | $744.9M | $804.4M | |
| Operating Income | $1.1B | $933.8M | $1B | $245.1M | $288.1M | |
| EBITDA | $1.7B | $1.6B | $1.7B | $401.9M | $455M | |
| Diluted EPS | $5.65 | $4.40 | $4.83 | $1.06 | $1.39 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $1.1B | $1.4B | $1.4B | $1.4B | |
| Total Assets | $9.6B | $11B | $11.5B | $12.3B | $11.8B | |
| Current Liabilities | $2.5B | $2.3B | $2B | $2B | $1.8B | |
| Total Liabilities | $6.4B | $7.4B | $7.6B | $7.6B | $6.8B | |
| Total Equity | $3.2B | $3.6B | $4B | $4.7B | $4.9B | |
| Total Debt | $4.4B | $5.3B | $5.8B | $5.7B | $5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $757.1M | $1.1B | $1.3B | $322.1M | $324.8M | |
| Cash From Investing | -$959.5M | -$878.2M | -$511.5M | -$153.5M | -$118.9M | |
| Cash From Financing | $273.7M | -$306.2M | -$846.4M | -$369.7M | -$501.4M | |
| Free Cash Flow | $132.6M | $515.5M | $813M | $176.4M | $205.9M | |
EFX
Sector
Market Cap
$30.2B
$600.1M
Price % of 52-Week High
78.66%
72.84%
Dividend Yield
0.64%
0%
Shareholder Yield
--
2.42%
1-Year Price Total Return
-8.96%
-7.65%
Beta (5-Year)
1.652
0.782
Dividend yield:
0.64%
Annualized payout:
$1.56
Payout ratio:
31.98%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$243.20
200-day SMA
Sell
Level
$265.48
Bollinger Bands (100)
Sell
Level
244.41 - 266.69
Chaikin Money Flow
Buy
Level
608.1K
20-day SMA
Buy
Level
$242.41
Relative Strength Index (RSI14)
Sell
Level
48.93
ADX Line
Buy
Level
15.05
Williams %R
Neutral
Level
-26.1688
50-day SMA
Sell
Level
$252.00
MACD (12, 26)
Buy
Level
67.36
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
2.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.2164)
Sell
CA Score
(Annual)
Level (-0.4035)
Buy
Beneish M-Score
(Annual)
Level (-2.7078)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.2607)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax’s credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders’ credit decisions. In addition, over 40% of the firm’s revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
Stock Forecast FAQ
In the current month, EFX has received 10 Buy ratings 5 Hold ratings, and 0 Sell ratings. The EFX average analyst price target in the past 3 months is $289.64.
-
Where Will Equifax Stock Be In 1 Year?
According to analysts, the consensus estimate is that Equifax share price will rise to $289.64 per share over the next 12 months.
-
What Do Analysts Say About Equifax?
Analysts are divided on their view about Equifax share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Equifax is a Sell and believe this share price will drop from its current level to $264.00.
-
What Is Equifax's Price Target?
The price target for Equifax over the next 1-year time period is forecast to be $289.64 according to 15 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is EFX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Equifax is a Buy. 10 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EFX?
You can purchase shares of Equifax via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Equifax shares.
-
What Is The Equifax Share Price Today?
Equifax was last trading at $243.33 per share. This represents the most recent stock quote for Equifax. Yesterday, Equifax closed at $243.56 per share.
-
How To Buy Equifax Stock Online?
In order to purchase Equifax stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 17.13% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 13.27% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 3.9% over the past day.
